Chemokine C-X-C-Motif Receptor 7 (CXCR7) Antibody

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
52€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Chemokine C-X-C-Motif Receptor 7 (CXCR7) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx015223
tested applications
ELISA, WB, IF/ICC

Description

Rabbit polyclonal antibody against CXCR7 protein. Immunogen region is C-terminal.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetChemokine C-X-C-Motif Receptor 7 (CXCR7)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionWB: 1/500 - 1/3000, IF/ICC: 1/100 - 1/500, ELISA: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationPurified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Size 110 µg
Size 2100 µg
Size 3200 µg
Size 4300 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA, WB, IF/ICC
BufferPBS (without Mg<sup>2+</sup> and Ca<sup>2+</sup>), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP25106
Aliaschemokine (C-X-C motif) receptor 7,chemokine orphan receptor 1,CXCR7,Cxcr7,GPR159 ,G-protein coupled receptor 159,RDC-1,RDC1,CMKOR1
BackgroundAntibody anti-ACKR3
StatusRUO
NoteConcentration: 1 mg/ml -

Descripción

ACKR3, also known as CXCR7, is an atypical chemokine receptor that binds CXCL12 and CXCL11 but does not trigger classical G protein signaling. Instead, it functions as a "scavenger receptor," internalizing and degrading chemokines to regulate their extracellular levels. ACKR3 is expressed on endothelial cells, smooth muscle cells, and cancer cells and plays a critical role in modulating chemokine gradients, which control immune cell migration. In cancer, ACKR3 is frequently overexpressed and promotes tumor growth, survival, and metastasis by scavenging CXCL12, enhancing CXCR4-mediated signaling. It is involved in glioblastoma, breast, and prostate cancers, where its expression correlates with poor prognosis and therapy resistance. ACKR3 also contributes to angiogenesis by promoting endothelial cell migration and tube formation. In the central nervous system, it regulates CXCL12 availability, impacting neurogenesis and neuronal repair. While it does not induce typical signaling, ACKR3 activates β-arrestin-dependent pathways that influence cellular adhesion, survival, and proliferation. Its atypical signaling and scavenging activity make ACKR3 an attractive target for cancer therapy and inflammatory disease treatment.

Related Products

EH2458

Human CXCR7(C-X-C chemokine receptor type 7) ELISA Kit

Ver Producto
ER1593

Rat CXCR7(C-X-C motif receptor 7) ELISA Kit

Ver Producto
FNab02104

anti- CXCR7 antibody

Ver Producto